Bell Investment Advisors, Inc
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1890149
ORINDA, CA
Position in PTGX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$10,541
+$2,004 QoQ
Shares Held
86
+6.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#299
of 341 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bell Investment Advisors, Inc holds $389,495 across 65 Biotechnology names. PTGX ranks #11 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
150 | $74,509 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,446 | $51,173 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
112 | $20,975 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32 | $19,953 | |
| 5 | ARGX |
Argenx SE
|
20 | $18,555 | |
| 6 | INCY |
Incyte Corp
|
156 | $17,684 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
223 | $16,609 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
49 | $14,750 |
All Filings in PTGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,541 | 86 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,537 | 81 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $7,074 | 81 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $5,380 | 81 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $4,476 | 81 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,499 | 31 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $656 | 17 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $765 | 17 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $589 | 17 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $491 | 17 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||